These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 36414698)
21. Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT. Devillier R; Galimard JE; Labopin M; Blaise D; Raiola AM; Pavlu J; Castagna L; Socié G; Chalandon Y; Martino M; Stölzel F; Bug G; Bruno B; Vrhovac R; Charbonnier A; Olivieri A; Bay JO; Arroyo H; Yakoub-Agha I; Avenoso D; Neubauer A; Nguyen S; Forcade E; Brissot E; Savani B; Nagler A; Mohty M Bone Marrow Transplant; 2022 Sep; 57(9):1421-1427. PubMed ID: 35752739 [TBL] [Abstract][Full Text] [Related]
22. T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT). Sestili S; Labopin M; Ruggeri A; Velardi A; Ciceri F; Maertens J; Kanz L; Aversa F; Lewalle P; Bunjes D; Mohty M; Nagler A Cancer; 2018 May; 124(10):2142-2150. PubMed ID: 29469924 [TBL] [Abstract][Full Text] [Related]
23. Endothelial Activation and Stress Index in adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based prophylaxis. Escribano-Serrat S; Rodríguez-Lobato LG; Charry P; Martínez-Cibrian N; Suárez-Lledó M; Rivero A; Moreno-Castaño AB; Solano MT; Arcarons J; Nomdedeu M; Cid J; Lozano M; Pedraza A; Rosiñol L; Esteve J; Urbano-Ispizua Á; Palomo M; Fernández-Avilés F; Martínez C; Díaz-Ricart M; Carreras E; Rovira M; Salas MQ Cytotherapy; 2024 Jan; 26(1):73-80. PubMed ID: 37952139 [TBL] [Abstract][Full Text] [Related]
24. Endothelial Activation and Stress Index (EASIX) at Admission Predicts Fluid Overload in Recipients of Allogeneic Stem Cell Transplantation. Varma A; Rondon G; Srour SA; Chen J; Ledesma C; Champlin RE; Ciurea SO; Saliba RM Biol Blood Marrow Transplant; 2020 May; 26(5):1013-1020. PubMed ID: 32045652 [TBL] [Abstract][Full Text] [Related]
25. Pretransplantation EASIX predicts intensive care unit admission in allogeneic hematopoietic cell transplantation. Peña M; Salas MQ; Mussetti A; Moreno-Gonzalez G; Bosch A; Patiño B; Jiménez L; Kara M; Parody R; Sureda A Blood Adv; 2021 Sep; 5(17):3418-3426. PubMed ID: 34495311 [TBL] [Abstract][Full Text] [Related]
26. Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia 45 years of age and over. Santoro N; Labopin M; Ciceri F; Van Lint MT; Nasso D; Blaise D; Arcese W; Tischer J; Bruno B; Ehninger G; Koc Y; Santarone S; Huang XJ; Savani BN; Mohty M; Ruggeri A; Nagler A Cancer; 2019 May; 125(9):1499-1506. PubMed ID: 30620383 [TBL] [Abstract][Full Text] [Related]
27. T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors. Mariotti J; Devillier R; Bramanti S; Sarina B; Furst S; Granata A; Faucher C; Harbi S; Morabito L; Chabannon C; Carlo-Stella C; Bouabdallah R; Santoro A; Blaise D; Castagna L Biol Blood Marrow Transplant; 2018 Mar; 24(3):627-632. PubMed ID: 29197681 [TBL] [Abstract][Full Text] [Related]
28. Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide. Ruggeri A; Labopin M; Bacigalupo A; Gülbas Z; Koc Y; Blaise D; Bruno B; Irrera G; Tischer J; Diez-Martin JL; Castagna L; Ciceri F; Mohty M; Nagler A Cancer; 2018 Apr; 124(7):1428-1437. PubMed ID: 29360162 [TBL] [Abstract][Full Text] [Related]
29. Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT. Santoro N; Ruggeri A; Labopin M; Bacigalupo A; Ciceri F; Gülbaş Z; Huang H; Afanasyev B; Arcese W; Wu D; Koc Y; Tischer J; Santarone S; Giebel S; Mohty M; Nagler A J Hematol Oncol; 2017 May; 10(1):113. PubMed ID: 28558762 [TBL] [Abstract][Full Text] [Related]
30. Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome. Alanazi W; Chen S; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law AD; Al-Shaibani Z; Mattsson J; Michelis FV Acta Haematol; 2021; 144(1):66-73. PubMed ID: 32428903 [TBL] [Abstract][Full Text] [Related]
31. Outcomes of Unmanipulated Haploidentical Transplantation Using Post-Transplant Cyclophosphamide (PT-Cy) in Pediatric Patients With Acute Lymphoblastic Leukemia. Ruggeri A; Galimard JE; Paina O; Fagioli F; Tbakhi A; Yesilipek A; Navarro JMF; Faraci M; Hamladji RM; Skorobogatova E; Al-Seraihy A; Sundin M; Herrera C; Rifón J; Dalissier A; Locatelli F; Rocha V; Corbacioglu S Transplant Cell Ther; 2021 May; 27(5):424.e1-424.e9. PubMed ID: 33965182 [TBL] [Abstract][Full Text] [Related]
32. Comparison of Pretransplantation Prediction Models for Nonrelapse Mortality in Patients with Myelofibrosis Undergoing Allogeneic Stem Cell Transplantation. Acosta-Medina AA; Baranwal A; Johnson IM; Kharfan-Dabaja MA; Murthy H; Palmer JM; Sproat L; Mangaonkar A; Shah MV; Hogan WJ; Litzow MR; Tefferi A; Alkhateeb HB Transplant Cell Ther; 2023 Jun; 29(6):360.e1-360.e8. PubMed ID: 36773650 [TBL] [Abstract][Full Text] [Related]
33. Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy. Mariotti J; Raiola AM; Evangelista A; Carella AM; Martino M; Patriarca F; Risitano A; Bramanti S; Busca A; Giaccone L; Brunello L; Merla E; Savino L; Loteta B; Console G; Fanin R; Sperotto A; Marano L; Marotta S; Frieri C; Sica S; Chiusolo P; Harbi S; Furst S; Santoro A; Bacigalupo A; Blaise D; Angelucci E; Mavilio D; Castagna L; Bruno B Blood Adv; 2020 Aug; 4(16):3900-3912. PubMed ID: 32813875 [TBL] [Abstract][Full Text] [Related]
34. Haploidentical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography. Marani C; Raiola AM; Morbelli S; Dominietto A; Ferrarazzo G; Avenoso D; Giannoni L; Varaldo R; Gualandi F; Grazia D; Lamparelli T; Bregante S; Van Lint MT; Ibatici A; Bovis F; Lemoli RM; Gobbi M; Bacigalupo A; Angelucci E Biol Blood Marrow Transplant; 2018 Dec; 24(12):2501-2508. PubMed ID: 30041010 [TBL] [Abstract][Full Text] [Related]
35. Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission. Konuma T; Kanda J; Yamasaki S; Harada K; Shimomura Y; Terakura S; Mizuno S; Uchida N; Tanaka M; Doki N; Ozawa Y; Nakamae H; Sawa M; Matsuoka KI; Morishige S; Maruyama Y; Ikegame K; Kimura T; Kanda Y; Ichinohe T; Atsuta Y; Yanada M Transplant Cell Ther; 2021 Apr; 27(4):334.e1-334.e11. PubMed ID: 33836881 [TBL] [Abstract][Full Text] [Related]
36. Comparable outcomes of haploidentical transplant with TBF conditioning versus matched unrelated donor with fludarabine/busulfan conditioning for acute myeloid leukemia. Bazarbachi A; Labopin M; Blaise D; Forcade E; Socié G; Berceanu A; Angelucci E; Bulabois CE; Kröger N; Rambaldi A; Ceballos P; Mielke S; El Cheikh J; Yakoub-Agha I; Savani B; Spyridonidis A; Nagler A; Mohty M Bone Marrow Transplant; 2021 Mar; 56(3):622-634. PubMed ID: 33020591 [TBL] [Abstract][Full Text] [Related]
37. Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia. Baron F; Labopin M; Tischer J; Ciceri F; Raiola AM; Blaise D; Sica S; Vydra J; Fanin R; Diez-Martin JL; Bulabois CE; Stölzel F; Busca A; Jindra P; Koc Y; Chevallier P; Forcade E; Rösler W; Passweg J; Kulagin A; Carella AM; Simand C; Bazarbachi A; Pioltelli P; Nagler A; Mohty M Bone Marrow Transplant; 2022 Nov; 57(11):1657-1663. PubMed ID: 35978005 [TBL] [Abstract][Full Text] [Related]
38. Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Salvatore D; Labopin M; Ruggeri A; Battipaglia G; Ghavamzadeh A; Ciceri F; Blaise D; Arcese W; Sociè G; Bourhis JH; Van Lint MT; Bruno B; Huynh A; Santarone S; Deconinck E; Mohty M; Nagler A Haematologica; 2018 Aug; 103(8):1317-1328. PubMed ID: 29748438 [TBL] [Abstract][Full Text] [Related]
39. Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute Leukemia. Nagler A; Labopin M; Dholaria B; Angelucci E; Afanasyev B; Cornelissen JJ; Sica S; Meijer E; Ciceri F; Van Gorkom G; Kröger N; Martin H; Pioltelli P; Risitano A; Canaani J; Savani BN; Sanz J; Mohty M Clin Cancer Res; 2021 Feb; 27(3):843-851. PubMed ID: 33148668 [TBL] [Abstract][Full Text] [Related]
40. Posttransplant cyclophosphamide-based anti-graft-vs-host disease prophylaxis in patients with acute lymphoblastic leukemia treated in complete remission with allogeneic hematopoietic cell transplantation from human leukocyte antigen-mismatched unrelated donors versus haploidentical donors: A study on behalf of the ALWP of the EBMT. Nagler A; Labopin M; Arat M; Reményi P; Koc Y; Blaise D; Angelucci E; Vydra J; Kulagin A; Socié G; Rovira M; Sica S; Aljurf M; Gülbas Z; Kröger N; Brissot E; Peric Z; Giebel S; Ciceri F; Mohty M Cancer; 2022 Nov; 128(22):3959-3968. PubMed ID: 36110063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]